BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma
Clinical trial NCT05322590 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05322590
- Sponsor
- Bexion Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-09
- Primary completion
- 2026-04-01
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.